VIMIZIM Trademark

Trademark Overview

On Tuesday, April 17, 2012, a trademark application was filed for VIMIZIM with the United States Patent and Trademark Office. The USPTO has given the VIMIZIM trademark a serial number of 85599526. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, July 27, 2024. This trademark is owned by Biomarin Pharmaceutical, Inc.. The VIMIZIM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in enzyme therapy
vimizim

General Information

Serial Number85599526
Word MarkVIMIZIM
Filing DateTuesday, April 17, 2012
Status800 - REGISTERED AND RENEWED
Status DateSaturday, July 27, 2024
Registration Number4538367
Registration DateTuesday, May 27, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2012

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in enzyme therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 24, 2012
Primary Code005
First Use Anywhere DateTuesday, February 18, 2014
First Use In Commerce DateTuesday, February 18, 2014

Trademark Owner History

Party NameBiomarin Pharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Tuesday, September 11, 2012PUBLISHED FOR OPPOSITION
Tuesday, September 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 20, 2012NEW APPLICATION ENTERED
Tuesday, April 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 1, 2012ASSIGNED TO EXAMINER
Friday, August 3, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2013SOU TEAS EXTENSION RECEIVED
Monday, April 1, 2013SOU EXTENSION 1 FILED
Monday, April 1, 2013SOU EXTENSION 1 GRANTED
Monday, September 16, 2013SOU EXTENSION 2 FILED
Wednesday, October 16, 2013SOU EXTENSION 2 GRANTED
Thursday, March 6, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, March 6, 2014USE AMENDMENT FILED
Wednesday, April 9, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 10, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2013SOU TEAS EXTENSION RECEIVED
Friday, October 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 24, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 27, 2014REGISTERED-PRINCIPAL REGISTER
Monday, May 27, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 5, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 1, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 1, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 1, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, May 27, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, July 27, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 27, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, May 6, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, July 27, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, July 27, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

vimizim pharmaceutical preparations enzyme therapy disorders genetic treatment diseases